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Abstract The main objective of this work was a comparative
evaluation of hepatoprotective activity of pyrimidine deriva-
tive of the active compound of Xymedon (1-(ß-oxyethyl)-4.6-
dimethyl-1.2-dihydro-2-oxopirimidon) and its derivatives
with methionine and ascorbic acid. The experiment was con-
ducted on nonlinear white rats of both sexes based on the
model of toxic damage inflicted on liver by CCl4 with pro-
phylactic scheme. The compounds were injected at doses of
1/500 LD50 (13 mg/kg for Xymedon and 11 mg/kg for its
derivatives with ascorbic acid and methionine). The study
showed that, out of the three compounds considered, the
Xymedon derivative with ascorbic acid had the most promi-
nent hepatoprotective properties, as, given the CCl4 poison-
ing, it caused the greatest decrease of liver damage area (by a
factor of 3.25 over control) and change of the largest number
of biochemical markers towards normalization. The Xymedon
der iva t ive wi th meth ionine had less prominent
hepatoprotective properties than both the derivative with
ascorbic acid and Xymedon itself.
Keywords Toxic hepatitis . Liver injure . Carbon
tetrachloride . Pyrimidine derivatives . Hepatoprotective
agents . Hepatoprotector
1 Introduction
As the incidence of liver diseases is increasing, researches
aimed to discover effective hepatoprotective medication are
getting ever more relevant. The best known drugs among oth-
er hepatoprotectors are based on plant matters, such as
silymarin or essential phospholipids [1, 2]. Contemporary lit-
erature includes a wide range of researches aimed to discover
new hepatoprotectors among plant extracts and natural com-
pounds [3]. Synthetic hepatoprotective agents are less known.
For instance, these include a drug called Thiotriazoline. There
is not much reported information about the hepatoprotective
activity of pyrimidine derivatives; however, this group of
compounds commands attention due to their property to stim-
ulate tissue regeneration. There are some works describing
mild hepatoprotective properties of uracil derivatives
(methyluracil, 4-methyl-5-oxymethyluracil) [4, 5], as well as
hepatoprotective properties of synthetic derivatives of 2,4-
dioxo-5-arylidenimino-1,3-pyrimidines [6]. We have previ-
ously obtained the results on hepatoprotective activity of a
Russian pyrimidine derivative-based drug, Xymedon [7],
and its derivative with ascorbic acid [8]. Moreover, we have
obtained results proving the actoprotective [9, 10] and neuro-
protective [11] activity of Xymedon derivatives.
The main idea of the synthesis of drug Xymedon deriva-
tives with biogenic molecules is improvement of hepatopro-
tective properties. As biogenic acids, we used ascorbic acid, a
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